Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effects of three chelating agents, sodium N-benzyl-D-glucamine dithiocarbamate(NBG-DTC), 2,3-dimercaptopropanol(
BAL
), and D-penicillamine(D-PEN), on the distribution, excretion, and renal toxicity of inorganic mercury were compared in rats exposed to HgCl2. Rats were injected i.p. with 203HgCl2 (300 micrograms of Hg and 2 microCi of 203Hg/kg) and 30 min or 24 h later they were injected with a chelating agent (a quarter of an LD50). The injection of the chelating agents significantly enhanced the biliary and urinary excretions of mercury.
BAL
was the most effective for removal of mercury from the body at 30 min after mercury treatment. The extent of enhancing effect of the chelating agents for removal of mercury at 24 h after mercury was in the order NBG-DTC =
BAL
greater than D-
PEN
. The injection of
BAL
at 24 h after mercury treatment caused the redistribution of mercury to the heart and lung. NBG-DTC did not result in the redistribution of mercury to the heart, lung, and brain. Urinary excretion of protein and AST significantly increased 24-48 h after mercury treatment and decreased to the control values 72 h after mercury. The injection of the chelating agents at 30 min after mercury treatment significantly decreased the urinary excretion of protein and AST. In rats pretreated with mercury 24 h earlier, the chelating agents significantly decreased the urinary protein at 48 h after mercury treatment, but did not decrease the urinary AST. The results of this study indicate that the chelating agents are effective in removing mercury from the body, resulting in the protective effect against the mercury-induced renal damage.
...
PMID:Comparative effects of chelating agents on distribution, excretion, and renal toxicity of inorganic mercury in rats. 278 Nov 44
The effects of the chelating agents Na2Ca-ethylendiaminetetraacetate (EDTA), Na3Ca-diethylentriaminepentaacetate (DTPA), L-cysteine, 2,3-dimercaptosuccinic acid (DMSA), N-acetyl-L-cysteine (NAC), glutathione, D,L-penicillamine (D,L-
PEN
) and 2,3-dimercaptopropanol (
BAL
) on the toxicity, distribution and excretion of intraperitoneally injected cobalt were studied in male Swiss mice. To determine the effect of the various chelators on the toxicity of cobalt, various doses of CoCl2 (0.60-1.80 mmol/kg) were given, followed immediately by the IP administration of the chelator (at a dose equal to one-fourth of their respective LD50). EDTA and DTPA were the most effective. EDTA, DTPA and L-cysteine, NAC and glutathione were also the most effective in increasing the urinary excretion of cobalt and reducing the concentration of the metal in various tissues. EDTA appears to be the most effective agent of those tested in the prevention of acute cobalt intoxication.
...
PMID:Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion and distribution of cobalt. 308 29
The effect of several chelating agents (diethyldithiocarbamic acid, DDC; nitrilotriacetic acid, NTA; 2,3-dimercaptopropanol,
BAL
; d,l-penicillamine,
PEN
; 2,3-dimercaptosuccinic acid, DMSA; ethylenediaminetetraacetic acid, EDTA; and diethylenetriaminepentaacetic acid, DTPA) on the toxicity, distribution and excretion of cadmium (Cd) was determined in mice. When chelators were administered immediately after Cd, significant increases in survival were noted after treatment with DMSA, EDTA, and DTPA. DTPA, followed by EDTA and then DMSA, were consistently the most effective in decreasing the tissue concentrations of Cd and increasing the excretion of Cd. NTA,
BAL
, DDC and
PEN
had no beneficial effects. The effects of increasing the time interval between Cd administration and initiation of chelation therapy was determined by using a single administration of DTPA, EDTA, and DMSA. Mice treated immediately after Cd administration excreted approximately 50% of the administered dose of Cd compared to 0.2% in controls. Treatment with chelator at later times significantly increased Cd excretion but the magnitude of the effect was much less than that seen in mice treated immediately after Cd. To determine the role of MT in the acute decrease in chelator efficacy following Cd poisoning, rats were injected IV with Cd followed by DTPA at various times after Cd. Although DTPA reduced Cd content in the various organs when given immediately after Cd, the chelator was ineffective at all later times. Increases in hepatic and renal metallothionein (MT) did not occur until 2 hr after Cd, and did not coincide with the earlier drop in chelator efficacy. Blockade of MT synthesis by actinomycin D failed to eliminate this decreased DTPA effectiveness. Therefore, it appears that MT does not play an important role in the acute decrease in efficacy of chelation therapy for Cd poisoning. The effect of repeated daily administration of chelators on the distribution and excretion of Cd was studied by administering chelators daily for 5 days starting 48 hr after Cd. DTPA, EDTA, DMSA and
BAL
significantly increased the urinary elimination of Cd. Thus, mobilization of Cd into urine occurs with repeated chelation therapy, which may decrease tissue concentrations of Cd and reduce the toxicity of the metal.
...
PMID:Alteration of tissue disposition of cadmium by chelating agents. 673 58
Factors affecting the renal uptake of inorganic mercury were investigated using primary cultures of rat renal cortical epithelial (RCE) cells under protein- and amino acid-free conditions. The cells were isolated from kidneys of adult rats and cultured. Confluence of culture (cell density), monitored morphologically and by total protein content, was achieved on Day 5. The RCE cells were incubated with 1 microM Hg at 37 degrees C for 30 min, followed by washing with phosphate-buffered saline containing various chelating agents (i.e., EGTA,
PEN
, DMSA, and
BAL
) to remove the surface-bound, noninternalized Hg. A substantial portion of Hg was bound to the cell surface. The removal of Hg from these binding sites was dependent on the stability constants of the chelating agents for Hg and lipophilic
BAL
removed the most Hg. Hg accumulation by the cells was dependent on cell density and decreased as the cell culture became confluent, possibly due to the formation of tight junctions resulting in a majority of the Hg transport occurring through the apical membrane. As measured after
BAL
washing, metabolic inhibitors, NaF, DNP, and ouabain decreased Hg accumulation by 28% and low temperature (4 degrees C) decreased it by 62%. Dependence of Hg uptake on metabolic energy and temperature suggests that a part of Hg is transported via active transport system. The pronounced decrease of Hg uptake at 4 degrees C indicates that, in addition to active transport, Hg transport also involves simple diffusion, some of which is dependent on membrane fluidity. It is concluded that Hg transport in RCE cells through the apical membrane occurs mainly by diffusion, and to a smaller extent by active transport.
...
PMID:Mercury uptake by primary cultures of rat renal cortical epithelial cells. I. Effects of cell density, temperature, and metabolic inhibitors. 774 83
The effects of three chelating agents, N-benzyl-D-glucamine dithiocarbamate (BGD), 2,3-dimercaptopropanol (
BAL
) and D-penicillamine (D-PEN), on the excretion of mercury in rats exposed to mercuric chloride (HgCl2), the chemical forms of mercury compounds excreted in the bile and urine and the intestinal reabsorption of mercury compounds in the bile were studied. Rats were injected intraperitoneally with 203HgCl2 (300 micrograms Hg and 74 kBq of 203Hg/kg) and 24 h later, they were injected intraperitoneally with a chelating agent (a quarter of an LD50). The injection of the chelating agents significantly enhanced the biliary and urinary excretions of mercury. The enhancing effect of BGD on the excretions of mercury was almost the same as that of
BAL
and much larger than that of D-
PEN
. The major chemical form of mercury in the bile and urine of rats injected with BGD after HgCl2 treatment was Hg-BGD compounds. The chemical form of mercury in the bile and urine of rats injected with
BAL
after HgCl2 treatment was mainly Hg-GSH compound. The mercury after HgCl2 and D-
PEN
treatment was excreted mainly via the urine in the form of Hg-D-
PEN
compound. The intestinal reabsorption of mercury from the bile of rats injected with BGD or D-
PEN
was only 0.18% or 0.38% of the dose, respectively. The intestinal reabsorption of mercury from the bile of rats injected with
BAL
was 27.38% of the dose. It was suggested that the Hg-GSH compound excreted in the bile after HgCl2 and
BAL
treatment is partly degraded to Hg-cysteine (Cys) by the intestinal membranous enzymes and that the ligand of Hg-Cys is replaced by
BAL
in the bile, resulting in the effective reabsorption of Hg-
BAL
compound from the intestine.
...
PMID:Further study of effects of chelating agents on excretion of inorganic mercury in rats. 844 11
When terbium chloride (TbCl(3)) was intravenously injected into mice, terbium (Tb) was mainly distributed into the spleen, lung, and liver. Thus, the effects of five chelating agents on the distribution of Tb to the spleen, lung, and liver of mice were examined. The treatments with diethyldithiocarbamate (DDTC), N-p-methoxybenzyl-D-glucamine dithiocarbamate (MeOBGD) and 2,3-dimercaptopropanol (
BAL
) reduced the content of Tb in the spleen. The treatments with D-penicillamine (D-PEN), ethylenediaminetetraacetic acid (EDTA), and MeOBGD reduced the content of Tb in the lung. However,
BAL
treatment enhanced the content of Tb in the lung, indicating the redistribution of Tb to the tissue. Although the biliary excretion of Tb was significantly increased in mice treated with EDTA and MeOBGD, these increases were negligibly small, and the metal was not detected in the urine. These results indicate that well-known chelating agents such as D-
PEN
, EDTA, DDTC, MeOBGD, and
BAL
have little ability to excrete Tb into the bile and urine. Further studies are necessary to develop a new type of chelating agent to remove Tb effectively from the body.
...
PMID:Effects of chelating agents on distribution and excretion of terbium in mice. 2002 Oct 81